Busting the protein link to Alzheimer’s

Israeli biotech MemoryPlus has developed a peptide to block the interaction of proteins PTEN & PSD-95, that causes memory loss in Alzheimer’s patients. The disease makes excessive PTEN, which attacks PSD-95, weakening the brain’s synapses. The peptide also lowers PTEN levels.




This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *